Johan Hartmans forskargrupp

Johan Hartmans forskargrupp
Johan Hartman group

 

Mer information finns på den engelska sidan.

Gruppmedlemmar

Johan Hartman, professor, forskargruppledare
Emelie Karlsson, forskningssamordnare
Stephanie Robertson, MD, PhD postdoc
Caroline Rönnlund, MD, doktorand
Caroline Schagerholm, MD, doktorand
Qiao Yang, doktorand
Balazs Acs, MD, PhD, postdoc
Xinsong Chen, postdoc
Elin Hardell, MD, PhD, postdoc
Ceren Boyaci, MD, anknuten

Utvalda publikationer

Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study.
Acs B, Fredriksson I, Rönnlund C, Hagerling C, Ehinger A, Kovács A, Røge R, Bergh J, Hartman J
Cancers (Basel) 2021 Mar;13(5):

Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression-morphology analysis in breast cancer.
Wang Y, Kartasalo K, Weitz P, Acs B, Valkonen M, Larsson C, Ruusuvuori P, Hartman J, Rantalainen M
Cancer Res 2021 Aug;():

CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.
Neo SY, Yang Y, Record J, Ma R, Chen X, Chen Z, Tobin NP, Blake E, Seitz C, Thomas R, Wagner AK, Andersson J, de Boniface J, Bergh J, Murray S, Alici E, Childs R, Johansson M, Westerberg LS, Haglund F, Hartman J, Lundqvist A
J Clin Invest 2020 03;130(3):1185-1198

Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes.
Ullah I, Karthik GM, Alkodsi A, Kjällquist U, Stålhammar G, Lövrot J, et al
J. Clin. Invest. 2018 04;128(4):1355-1370

Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.
Ma R, Karthik GM, Lövrot J, Haglund F, Rosin G, Katchy A, et al
J. Natl. Cancer Inst. 2017 03;109(3):1-14

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M, Klevebring D, Lindberg J, Ivansson E, Rosin G, Kis L, et al
Sci Rep 2016 11;6():38037

Digital image analysis outperforms manual biomarker assessment in breast cancer.
Stålhammar G, Fuentes Martinez N, Lippert M, Tobin NP, Mølholm I, Kis L, et al
Mod. Pathol. 2016 Apr;29(4):318-29

mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells.
Karthik GM, Ma R, Lövrot J, Kis LL, Lindh C, Blomquist L, et al
Cancer Lett. 2015 Oct;367(1):76-87

Digital image analysis in breast pathology-from image processing techniques to artificial intelligence.
Robertson S, Azizpour H, Smith K, Hartman J
Transl Res 2018 04;194():19-35